Crossject (ALCJ) - Total Liabilities

Latest as of December 2025: €35.30 Million EUR ≈ $41.27 Million USD

Based on the latest financial reports, Crossject (ALCJ) has total liabilities worth €35.30 Million EUR (≈ $41.27 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Crossject annual equity growth to track the company's year-over-year net asset growth rate.

Crossject - Total Liabilities Trend (2010–2025)

This chart illustrates how Crossject's total liabilities have evolved over time, based on quarterly financial data.

Crossject Competitors by Total Liabilities

The table below lists competitors of Crossject ranked by their total liabilities.

Company	Country	Total Liabilities
Shinsegae Food KO:031440	Korea	₩445.57 Billion
Phoenix Group Holdings PLC LSE:PHNX	UK	GBX331.44 Billion
Cemacon Zalau RO:CEON	Romania	RON176.26 Million
CO2 Energy Transition Corp. Unit NASDAQ:NOEMU	USA	$2.69 Million
Nanjing Panda Electronics Company Limited F:NNJ	Germany	€1.99 Billion
TAT HONG EQ.SRV. DL-08 F:1Q2	Germany	€1.74 Billion
Hurriyet Gazetecilik ve Matbaacilik AS IS:HURGZ	Turkey	TL2.59 Billion
CFSB Bancorp Inc NASDAQ:CFSB	USA	$290.87 Million

Liability Composition Analysis (2010–2025)

This chart breaks down Crossject's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Crossject market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.35	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-7.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Crossject's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Crossject (2010–2025)

The table below shows the annual total liabilities of Crossject from 2010 to 2025.

Year	Total Liabilities	Change
2025-12-31	€35.30 Million ≈ $41.27 Million	+3.10%
2024-12-31	€34.24 Million ≈ $40.03 Million	+0.97%
2023-12-31	€33.91 Million ≈ $39.64 Million	+12.38%
2022-12-31	€30.17 Million ≈ $35.28 Million	-18.46%
2021-12-31	€37.01 Million ≈ $43.26 Million	+6.58%
2020-12-31	€34.72 Million ≈ $40.59 Million	+61.63%
2019-12-31	€21.48 Million ≈ $25.11 Million	+16.08%
2018-12-31	€18.50 Million ≈ $21.63 Million	+59.11%
2017-12-31	€11.63 Million ≈ $13.60 Million	+46.01%
2016-12-31	€7.97 Million ≈ $9.31 Million	+56.75%
2015-12-31	€5.08 Million ≈ $5.94 Million	+30.64%
2014-12-31	€3.89 Million ≈ $4.55 Million	-17.28%
2013-12-31	€4.70 Million ≈ $5.50 Million	+4.54%
2012-12-31	€4.50 Million ≈ $5.26 Million	-10.71%
2011-12-31	€5.04 Million ≈ $5.89 Million	-54.46%
2010-12-31	€11.06 Million ≈ $12.93 Million	--

About Crossject

PA:ALCJ France Medical Instruments & Supplies

Market Cap

$93.38 Million

€79.87 Million EUR

Market Cap Rank

#19378 Global

#293 in France

Share Price

€1.50

Change (1 day)

+0.00%

52-Week Range

€1.40 - €2.69

All Time High

€10.40